Nippon Express has announced it will be joining the KIX Pharma Community established by Kansai Airports (Yoshiyuki Yamaya, CEO) to acquire a CEIV Pharma pharmaceutical transport quality certification advocated by the IATA by the end of 2021.
Good Distribution Practice (GDP), a quality system used by the pharmaceuticals industry to ensure the proper distribution of pharmaceuticals, has been enshrined into law by the EU, and Japan published its own version of GDP guidelines on December 28, 2018, both initiatives indicative of global-level demand for tight control over the entire distribution chain from procurement of raw materials to supply of products to the final consumer.
The pharmaceutical industry has been positioned as a priority industry in the “Nippon Express Group Business Plan 2023 – ‘Dynamic Growth'”, and Nippon Express is working to develop a pharmaceutical supply network that achieves total optimisation of pharmaceutical logistics. Construction is underway of pharmaceutical centres that will constitute the core of this network, with the Kyushu facility having recently been completed and the West Japan, East Japan and Toyama centres to be finished soon.
By acquiring this certification encompassing the GDP standards of countries around the world, Nippon Express will be able to provide pharmaceutical transport services on a global basis from Kansai International Airport.
Source: Nippon Express
